GOLDMAN SACHS GROUP INC - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 40 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$45,000
-49.4%
27,588
+40.7%
0.00%
Q3 2019$89,000
-43.7%
19,604
+23.5%
0.00%
Q2 2019$158,000
-32.8%
15,875
-21.1%
0.00%
Q1 2019$235,000
+23.0%
20,131
+26.9%
0.00%
Q4 2018$191,000
-68.9%
15,869
-56.0%
0.00%
Q3 2018$615,000
-47.2%
36,079
-47.1%
0.00%
Q2 2018$1,165,00068,2230.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 375,000$3,739,0001.40%
CVI Holdings, LLC 223,140$2,226,0000.86%
MENORA MIVTACHIM HOLDINGS LTD. 2,202,456$21,958,0000.59%
Ion Asset Management Ltd. 225,000$2,243,0000.57%
Altshuler Shaham Ltd 1,093,859$11,343,0000.48%
MEITAV INVESTMENT HOUSE LTD 500,436$4,987,0000.33%
Clal Insurance Enterprises Holdings Ltd 595,000$5,932,0000.14%
New England Private Wealth Advisors LLC 50,000$499,0000.12%
EMERALD MUTUAL FUND ADVISERS TRUST 200,000$1,994,0000.08%
ING GROEP NV 30,000$299,0000.01%
View complete list of ELOXX PHARMACEUTICALS INC shareholders